Haemophilia trials in Netherlands
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Amsterdam, Groningen, Utrecht
- Age
- 12 years and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
- Where
- Utrecht
- Age
- 12 years and over
- People
- 138 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00 - No phaseEnrolling by invitationAdverse Event Data Collection From External Registries on Nonacog Beta Pegol
- Where
- Baarn
- People
- 10 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT03690336 - No phaseTaking peopleSynovial Proliferation on Routine Ultrasound: Active or Inactive?
- Where
- Utrecht
- Age
- 12 years and over
- People
- 46
- Run by
- Van Creveldkliniek
See details and how to joinNCT06809972 - No phaseNot yet taking people in NetherlandsSearching Patterns In the Robustness of Immunological FVIII Tolerance
- Where
- Amsterdam
- Age
- Up to 18 years
- People
- 500
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07539402 - Phase 4Taking peoplePharmacokinetic-guided dosing of emicizumab in congenital haemophilia A patients – The DosEmi study
- Where
- Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, 's-Gravenhage, Utrecht
- People
- 135
- Run by
- Universitair Medisch Centrum Utrecht
See details and how to joinNCT06320626 · EU 2024-515528-35-00 - No phaseTaking peopleThe European Paediatric Network for Haemophilia Management ( PedNet Registry)
- Where
- Utrecht
- People
- 4,000 worldwide
- Run by
- PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119 - Phase 2/3Enrolling by invitationLong-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
- Where
- Amsterdam, Groningen, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 56 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05962398 · EU 2023-503765-37-00